Amsterdam UMC, Locatie VUMC; Neurology

Amsterdam 1081 HV

0 studies enrolling now · 3 studies all time

What they study most

Chronic Lymphocytic Leukemia, Crohn Disease, Ulcerative Colitis

Studies at this site

• A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) — Completed
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors — Completed